An international study finds that AI surpasses average radiologists in detecting pancreatic cancer on CT scans using a newly developed benchmark and dataset.
Key Details
- 1The study was led by Radboudumc and published in The Lancet Oncology.
- 2A confidential dataset of nearly 400 patient CT scans was assessed by international experts and used to benchmark over 250 submitted AI models.
- 3The best AI model made correct assessments in 92% of scans, compared to 88% for radiologists, and produced 38% fewer false positives.
- 4The AI outperformed the average radiologist but requires further validation before clinical adoption.
- 5The research was funded by the Hanarth Fund and the EU’s Horizon Europe program.
Why It Matters
This study provides strong evidence for the potential of AI to support radiologists in diagnosing pancreatic cancer, a particularly deadly and hard-to-detect disease. The validated benchmark and international collaboration pave the way for further clinical development and adoption of AI in abdominal CT interpretation.
Source
EurekAlert
Related News
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
AI Analyzes 66,000 MRI Scans to Map Body Composition Risks
Researchers used AI to analyze over 66,000 whole-body MRI scans, creating a detailed body composition reference map linked to health risks.